Sign In
Buy GERN
$1.16
-0.0100 (-0.85%)
At Close: Jun 03, 2026
8 Anti-aging Stocks in the US | INN
03:00am, Thursday, 02'nd Jul 2020
It can be tough to find public anti-aging companies to invest in.
Geron Corporation (GERN), a late-stage clinical biopharmaceutical company, today announced that the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) issued a positive opi
Geron (NASDAQ:GERN) Rating Increased to Hold at BidaskClub
04:00am, Wednesday, 01'st Jul 2020
BidaskClub upgraded shares of Geron (NASDAQ:GERN) from a sell rating to a hold rating in a report released on Tuesday morning, BidAskClub reports. Other analysts also recently issued research reports
Zymeworks (NYSE:ZYME) & Ocular Therapeutix (NYSE:OCUL) Critical Comparison
02:38am, Wednesday, 01'st Jul 2020
Zymeworks (NYSE:ZYME) and Ocular Therapeutix (NASDAQ:OCUL) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their
Calidi Biotherapeutics Announces Appointment of Jim Schoeneck, Accomplished Biotech Executive, to Board of Directors
12:00am, Wednesday, 01'st Jul 2020
Calidi Biotherapeutics Announces Appointment of Jim Schoeneck, Accomplished Biotech Executive, to Board of Directors
Xconomy: Roche Gets FDA OK for Injectable Version of Breast Cancer Drug
02:07am, Tuesday, 30'th Jun 2020
A new version of a combination drug marketed by Roche for early-stage and metastatic breast cancer with a specific genetic signature received FDA approval
Zealand Announces Dosing Initiation in Type 2 Diabetes Study
02:36pm, Thursday, 25'th Jun 2020
Zealand's (ZEAL) partner, Boehringer Ingelheim, is developing BI 456906, a long-acting GLP-1/glucagon dual agonist, as a treatment for obesity and type 2 diabetes.
Geron's Shares March Higher, Can It Continue?
12:38pm, Thursday, 25'th Jun 2020
As of late, it has definitely been a great time to be an investor in Geron.
Brokers Are Upgrading Their Views On Geron Corporation (NASDAQ:GERN) With These New Forecasts
04:35pm, Wednesday, 24'th Jun 2020
Geron Corporation (NASDAQ:GERN) shareholders will have a reason to smile today, with the analysts making substantial...
Is Geron (GERN) Stock Outpacing Its Medical Peers This Year?
03:30pm, Wednesday, 24'th Jun 2020
Is (GERN) Outperforming Other Medical Stocks This Year?
Dynavax's Partner Doses First Patient in Coronavirus Study
03:28pm, Monday, 22'nd Jun 2020
Dynavax's (DVAX) China-based partner initiates dosing in a phase I study evaluating a COVID-19 vaccine using the company's proprietary CpG 1018 adjuvant. Preliminary data are expected in August.
Halozyme Therapeutics : To Receive $10 Million Milestone Payment From Janssen | MarketScreener
12:01pm, Monday, 22'nd Jun 2020Implied Volatility Surging for Geron Corporation (GERN) Stock Options
12:50pm, Friday, 19'th Jun 2020
Investors need to pay close attention to Geron Corporation (GERN) stock based on the movements in the options market lately.
Geron (GERN) Presents At KOL Event - Slideshow
05:39pm, Thursday, 18'th Jun 2020
The following slide deck was published by Geron Corporation in conjunction with this event.
